(Q24248713)

31 July 2017

31 July 2017

0 references

1 reference

title

Methylxanthines for exacerbations of chronic obstructive pulmonary disease (English)

1 reference

12804425

31 July 2017

Methyl-xanthines for exacerbations of chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

31 July 2017

0 references

2

B H Rowe

Brian H Rowe

2 references

31 July 2017

31 July 2017

3

C A Camargo

Carlos A Camargo

2 references

31 July 2017

31 July 2017

1

R Graham Barr

R G Barr

2 references

31 July 2017

31 July 2017

22 April 2003

0 references

1 January 2003

1 reference

12804425

31 July 2017

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

31 July 2017

2 references

31 July 2017

31 July 2017

CD002168

2 references

31 July 2017

31 July 2017

2

1 reference

12804425

31 July 2017

1

1 reference

Aminophylline Therapy for Acute Bronchospastic Disease in the Emergency Room

31 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

Rapid assay of serum theophylline levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

Noninvasive ventilation in acute respiratory failure--a meta-analysis update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

21 January 2018

Theophylline in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

Treatment of respiratory failure due to advanced chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

Comparison of intravenously administered doxofylline and placebo for the treatment of severe acute airways obstruction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

Comparative study of the effects of intravenous administration of aminophylline, salbutamol and terbutaline in patients suffering and from reversible airways obstruction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

Theophylline and Salbutamol Improve Pulmonary Function in Patients with Irreversible Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002168

7 January 2021

10.1002/14651858.CD002168

Identifiers

DOI

2 references

31 July 2017

31 July 2017

1 reference

31 July 2017

1 reference

11279755